Stay updated on APL-501 with APL-101 in HCC and RCC Clinical Trial
Sign up to get notified when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.

Latest updates to the APL-501 with APL-101 in HCC and RCC Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study record page now returns a 403 Forbidden error, replacing the usual content with a minimal error screen. This blocks access to core trial details, and the error page includes a Home button and a revision note.SummaryDifference19%

- Check47 days agoChange DetectedThe page's Revision label was updated from v3.6.5 to v3.6.6, indicating a new software build or patch. This appears to be a backend update rather than a modification to study text or data.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision tag was updated to v3.6.5, replacing the previous v3.6.4 in the page history.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision tag on the page updated to v3.6.4 from v3.6.3, signaling a minor update to the site's versioning rather than a substantive change to study information.SummaryDifference0.1%

- Check104 days agoChange DetectedThe page revision label updated from v3.6.2 to v3.6.3, indicating a new revision of the page. This reflects an administrative update to the page's metadata rather than changes to the study data.SummaryDifference0.1%

Stay in the know with updates to APL-501 with APL-101 in HCC and RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.